Current through Register Vol. 50, No. 9, September 20, 2024
A. A licensee shall control access to the
treatment room by a door at each entrance.
B. A licensee shall equip each entrance to
the treatment room with an electrical interlock system that will:
1. prevent the operator from initiating the
treatment cycle unless each treatment room entrance door is closed;
2. cause the source to be shielded when an
entrance door is opened; and
3.
prevent the source from being exposed following an interlock interruption until
all treatment room entrance doors are closed and the source "on-off" control is
reset at the console.
C.
A licensee shall require any individual entering the treatment room to ensure,
through the use of appropriate radiation monitors, that radiation levels have
returned to ambient levels.
D.
Except for low-dose remote afterloader units, a licensee shall construct or
equip each treatment room with viewing and intercom systems to permit
continuous observation of the patient or the human research subject from the
treatment console during irradiation.
E. For licensed activities where sources are
placed within the patient's or human research subject's body, a licensee shall
only conduct treatments that allow for expeditious removal of a decoupled or
jammed source.
F. In addition to
the requirements specified in Subsections A through E of this Section, a
licensee shall:
1. for medium dose-rate and
pulsed dose-rate remote afterloader units, require:
a. an authorized medical physicist and either
an authorized user or a physician, under the supervision of an authorized user,
who has been trained in the operation and emergency response for the unit, to
be physically present during the initiation of all patient treatments involving
the unit; and
b. an authorized
medical physicist and either an authorized user or an individual, under the
supervision of an authorized user, who has been trained to remove the source
applicator in the event of an emergency involving the unit, to be immediately
available during continuation of all patient treatments involving the
unit;
2. for high
dose-rate remote afterloader units, require:
a. an authorized medical physicist and an
authorized user to be physically present during the initiation of all patient
treatments involving the unit; and
b. an authorized medical physicist and either
an authorized user or a physician, under the supervision of an authorized user,
who has been trained in the operation and emergency response for the unit, to
be physically present during continuation of all patient treatments involving
the unit;
3. for gamma
stereotactic radiosurgery units, require an authorized medical physicist and an
authorized user to be physically present throughout all patient treatments
involving the unit;
4. notify the
radiation safety officer, or his/her designee, and an authorized user as soon
as possible if the patient or human research subject has a medical emergency or
dies.
G. A licensee
shall have applicable emergency response equipment available near each
treatment room to respond to a source:
1.
remaining in the unshielded position; or
2. lodged within the patient following
completion of the treatment.
AUTHORITY NOTE:
Promulgated in accordance with
R.S.
30:2001 et
seq.
